Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Michael J. Cork; Laurent Eckert; Eric L. Simpson; April Armstrong; Sebastien Barbarot; Luis Puig; Giampiero Girolomoni; Marjolein de Bruin-Weller; Andreas Wollenberg; Yoko Kataoka; Anita Remitz; Stefan Beissert; Vera Mastey; Marius Ardeleanu; Zhen Chen; Abhijit Gadkari; Jingdong Chao

doi:10.1080/09546634.2019.1612836

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Michael J. Cork, Laurent Eckert, Eric L. Simpson, April Armstrong, Sebastien Barbarot, Luis Puig, Giampiero Girolomoni, Marjolein de Bruin-Weller, Andreas Wollenberg, Yoko Kataoka, Anita Remitz, Stefan Beissert, Vera Mastey, Marius Ardeleanu, Zhen Chen, Abhijit Gadkari, Jingdong Chao

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Journal of Dermatological Treatment
Volume	31
Issue number	6
Pages (from-to)	606-614
Number of pages	9
ISSN	0954-6634
DOIs	https://doi.org/10.1080/09546634.2019.1612836
Publication status	Published - 17 Aug 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

Atopic dermatitis
dupilumab
patient-reported outcomes
quality of life
ADULT PATIENTS
HOSPITAL ANXIETY
GUIDELINES
MANAGEMENT
ECZEMA
MECHANISMS
DISEASE
PLACEBO
BURDEN
CARE
3141 Health care science

Access to Document

10.1080/09546634.2019.1612836Licence: CC BY-NC-ND

Dupilumab improves patient reported symptoms of atopic dermatitis symptoms of anxiety and depression and health related quality of life in moderateFinal published version, 1.42 MBLicence: CC BY-NC-ND

Cite this

Cork, M. J., Eckert, L., Simpson, E. L., Armstrong, A., Barbarot, S., Puig, L., Girolomoni, G., de Bruin-Weller, M., Wollenberg, A., Kataoka, Y., Remitz, A., Beissert, S., Mastey, V., Ardeleanu, M., Chen, Z., Gadkari, A., & Chao, J. (2020). Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Journal of Dermatological Treatment, 31(6), 606-614. https://doi.org/10.1080/09546634.2019.1612836

Cork, Michael J. ; Eckert, Laurent ; Simpson, Eric L. et al. / Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis : analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. In: Journal of Dermatological Treatment. 2020 ; Vol. 31, No. 6. pp. 606-614.

@article{bbfd64f29dc54d2d9c74b628a71f7ccd,

title = "Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2",

keywords = "Atopic dermatitis, dupilumab, patient-reported outcomes, quality of life, ADULT PATIENTS, HOSPITAL ANXIETY, GUIDELINES, MANAGEMENT, ECZEMA, MECHANISMS, DISEASE, PLACEBO, BURDEN, CARE, 3141 Health care science",

author = "Cork, {Michael J.} and Laurent Eckert and Simpson, {Eric L.} and April Armstrong and Sebastien Barbarot and Luis Puig and Giampiero Girolomoni and {de Bruin-Weller}, Marjolein and Andreas Wollenberg and Yoko Kataoka and Anita Remitz and Stefan Beissert and Vera Mastey and Marius Ardeleanu and Zhen Chen and Abhijit Gadkari and Jingdong Chao",

year = "2020",

month = aug,

day = "17",

doi = "10.1080/09546634.2019.1612836",

language = "English",

volume = "31",

pages = "606--614",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Taylor & Francis",

number = "6",

}

Cork, MJ, Eckert, L, Simpson, EL, Armstrong, A, Barbarot, S, Puig, L, Girolomoni, G, de Bruin-Weller, M, Wollenberg, A, Kataoka, Y, Remitz, A, Beissert, S, Mastey, V, Ardeleanu, M, Chen, Z, Gadkari, A & Chao, J 2020, 'Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2', Journal of Dermatological Treatment, vol. 31, no. 6, pp. 606-614. https://doi.org/10.1080/09546634.2019.1612836

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. / Cork, Michael J.; Eckert, Laurent; Simpson, Eric L. et al.
In: Journal of Dermatological Treatment, Vol. 31, No. 6, 17.08.2020, p. 606-614.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis

T2 - analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

AU - Cork, Michael J.

AU - Eckert, Laurent

AU - Simpson, Eric L.

AU - Armstrong, April

AU - Barbarot, Sebastien

AU - Puig, Luis

AU - Girolomoni, Giampiero

AU - de Bruin-Weller, Marjolein

AU - Wollenberg, Andreas

AU - Kataoka, Yoko

AU - Remitz, Anita

AU - Beissert, Stefan

AU - Mastey, Vera

AU - Ardeleanu, Marius

AU - Chen, Zhen

AU - Gadkari, Abhijit

AU - Chao, Jingdong

PY - 2020/8/17

Y1 - 2020/8/17

KW - Atopic dermatitis

KW - dupilumab

KW - patient-reported outcomes

KW - quality of life

KW - ADULT PATIENTS

KW - HOSPITAL ANXIETY

KW - GUIDELINES

KW - MANAGEMENT

KW - ECZEMA

KW - MECHANISMS

KW - DISEASE

KW - PLACEBO

KW - BURDEN

KW - CARE

KW - 3141 Health care science

U2 - 10.1080/09546634.2019.1612836

DO - 10.1080/09546634.2019.1612836

M3 - Article

SN - 0954-6634

VL - 31

SP - 606

EP - 614

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

IS - 6

ER -

Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L et al. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Journal of Dermatological Treatment. 2020 Aug 17;31(6):606-614. doi: 10.1080/09546634.2019.1612836